The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice
Physiological Reports · 2025
DOI: 10.14814/phy2.70424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Casey L Egan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Decorin, Adiposity, Physical Conditioning, Animal, Obesity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health | National Health and Medical Research Council (NHMRC), Direktør Throne Holsts Fond For Ernæringsforskning (Throne-Holst Foundation for Nutrition Research), National Health and Medical Research Council.
Abstract (Originalsprache)
Physical activity is associated with improvements in insulin sensitivity and muscle function. The proteoglycan decorin is increased in skeletal muscle and plasma in response to exercise, but the biological implications are unknown. We investigated the effects of decorin deficiency on obesity, glucose tolerance, and exercise adaptation in C57BL/6J mice. Decorin deficiency did not influence adiposity, insulin‐ and glucose‐ tolerance, or energy metabolism in obese, high fat diet fed mice ( Dcn −/− vs. Dcn +/+ ). Decorin is abundant in the skeletal muscle extracellular matrix, thus we further compared the skeletal muscle of Dcn −/− and Dcn +/+ littermates. There were no effects on muscle morphology or the expression of metabolic markers. Dcn −/− mice had normal exercise capacity measured as running distance on a treadmill. To study the effects of long‐term exercise, mice were housed with access to running wheels. Overall, there were no major differences in voluntary wheel running or skeletal muscle metabolic markers, but Dcn −/− mice had a tendency for reduced running wheel activity compared to Dcn +/+ mice. This was accompanied by a smaller exercise effect on metabolic markers in muscle Dcn −/− mice. Our findings indicate that decorin does not have a major impact on glucose tolerance, metabolic adaptation, or aerobic exercise performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
- Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
- Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Faculty of Science and Health, School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
- Cancer Epigenetic Biology and Therapeutics, Precision Medicine Theme, Children's Cancer Institute, Sydney, New South Wales, Australia.
- School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Edgbaston, UK.
ORCID-Profile: Marit Hjorth
Förderung
- Department of Health | National Health and Medical Research Council (NHMRC)
- Direktør Throne Holsts Fond For Ernæringsforskning (Throne-Holst Foundation for Nutrition Research)
- National Health and Medical Research Council
Zitieren
APA
Egan, C. L., Doncheva, A., Pal, M., Fox, S. L., Dalen, K. T., Whitham, M., Febbraio, M. A., & Hjorth, M. (2025). The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice. Physiological Reports. https://doi.org/10.14814/phy2.70424
Vancouver
Egan CL, Doncheva A, Pal M, Fox SL, Dalen KT, Whitham M, et al. The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice. Physiological Reports. 2025. doi:10.14814/phy2.70424
BibTeX
@article{Egan2025,
author = {Egan, Casey L and Doncheva, Atanaska and Pal, Martin and Fox, Sarah L and Dalen, Knut Tomas and Whitham, Martin and Febbraio, Mark A and Hjorth, Marit},
title = {The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70424}
}
EUVIMED